{"format":1,"id":"117-hr-8454","congress":117,"number":"H.R. 8454","kind":"bill","group":"bills","title":"Medical Marijuana and Cannabidiol Research Expansion Act","title_source":"Short Titles as Enacted","official_title":"To expand research on cannabidiol and marijuana, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To expand research on cannabidiol and marijuana, and for other purposes."},{"type":"Short Titles from ENR (Enrolled) bill text","title":"Medical Marijuana and Cannabidiol Research Expansion Act"},{"type":"Display Title","title":"Medical Marijuana and Cannabidiol Research Expansion Act"},{"type":"Short Titles as Enacted","title":"Medical Marijuana and Cannabidiol Research Expansion Act"},{"type":"Short Titles as Passed Senate","title":"Medical Marijuana and Cannabidiol Research Expansion Act"},{"type":"Short Title(s) as Passed House","title":"Medical Marijuana and Cannabidiol Research Expansion Act"},{"type":"Short Title(s) as Introduced","title":"Medical Marijuana and Cannabidiol Research Expansion Act"}],"outcome":"became_law","law_number":"Public Law 117-215","introduced":"2022-07-21","chambers":{"house":{"status":"roll_call","date":"2022-07-26","vote":{"id":"117-2022-h392","question":"On Motion to Suspend the Rules and Pass, as Amended","title":"Medical Marijuana and Cannabidiol Research Expansion Act","result":"Passed","yea":325,"nay":95,"present":0,"not_voting":10,"source":"https://clerk.house.gov/evs/2022/roll392.xml"}},"senate":{"status":"voice","date":"2022-11-16","vote":null,"how":"voice_vote","words":"Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote."}},"president":{"status":"signed","date":"2022-12-02"},"vice_president_tie_breaker":null,"latest_action":{"text":"Became Public Law No: 117-215.","date":"2022-12-02"},"nominees":null,"amendments":[],"other_votes":[],"crs_summary":{"date":"2022-12-02","stage":"Public Law","blocks":[{"k":"h","t":"Medical Marijuana and Cannabidiol Research Expansion Act"},{"k":"p","t":"This act establishes a new, separate registration process to facilitate research on marijuana."},{"k":"p","t":"Specifically, the act directs the Drug Enforcement Administration (DEA) to follow procedures specified in the act to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research."},{"k":"p","t":"The act allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the act directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative."},{"k":"p","t":"Finally, the act includes various other provisions, including provisions that"},{"k":"li","t":"require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes;","d":1},{"k":"li","t":"prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research;","d":1},{"k":"li","t":"allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and","d":1},{"k":"li","t":"require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle.","d":1}],"words":224},"summary":{"main_subject":{"text":"Sets up registration procedures under the Controlled Substances Act for research with marijuana and cannabidiol, and adds supply, security, physician-discussion and federal research reporting provisions.","cites":[{"label":"Sec. 101","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-H2BF5872350EA4EF6B285F78739733B4D:~:text=101.%20Marijuana%20research%20applications"},{"label":"Sec. 103","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-H48E18EAE16724A2AAD2C4A9A9B95BEED:~:text=103.%20Applications%20to%20manufacture%20marijuana%20for%20research"},{"label":"Sec. 201","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HF0E35C75578040C6A4473FDE9DB5D610:~:text=201.%20Medical%20research%20on%20cannabidiol"},{"label":"Sec. 202","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HD6D57EC81C054BF0877A60456D8F9298:~:text=202.%20Registration%20for%20the%20commercial%20production%20and"}]},"core_areas":["Registration of practitioners to conduct marijuana research","Registration of manufacturers to supply marijuana for research","Research use and commercial drug production involving marijuana and cannabidiol","Supply and security requirements for marijuana research","Physician discussions of marijuana and cannabidiol with patients","Federal report and research activities on marijuana and cannabidiol"],"what_it_does":[{"text":"Requires the Attorney General to register a practitioner to conduct research with marijuana if the research protocol has been reviewed and allowed as the text describes and the applicant shows effective safeguards against diversion.","cite":{"label":"Sec. 101","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-H2BF5872350EA4EF6B285F78739733B4D:~:text=101.%20Marijuana%20research%20applications"}},{"text":"Requires the Attorney General, within 60 days of receiving a completed application, to approve it or request supplemental information when the Attorney General has given notice in the Federal Register to increase the number of registered marijuana manufacturers supplying researchers.","cite":{"label":"Sec. 103","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-H48E18EAE16724A2AAD2C4A9A9B95BEED:~:text=103.%20Applications%20to%20manufacture%20marijuana%20for%20research"}},{"text":"Requires the Attorney General, on an annual basis and in consultation with the Secretary of Health and Human Services, to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes.","cite":{"label":"Sec. 104","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HB5A840D1432C4CBBB3B01E5FB893D84A:~:text=104.%20Adequate%20and%20uninterrupted%20supply"}},{"text":"Allows an appropriately registered covered institution of higher education, practitioner, or manufacturer to manufacture, distribute, dispense, or possess marijuana or cannabidiol for medical research for drug development or subsequent commercial production.","cite":{"label":"Sec. 201","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HF0E35C75578040C6A4473FDE9DB5D610:~:text=201.%20Medical%20research%20on%20cannabidiol"}},{"text":"Provides that it is not a violation of the Controlled Substances Act for a State-licensed physician to discuss the currently known potential harms and benefits of marijuana and its derivatives, including cannabidiol, as a treatment with a patient or the patient's legal guardian, as the text specifies.","cite":{"label":"Sec. 301","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HCB35A842437E4E409D377F3F7EC66516"}},{"text":"Requires the Secretary of Health and Human Services, within 1 year of enactment and in coordination with the Director of the National Institutes of Health and other agencies, to submit a report to congressional committees on the therapeutic effects, other effects, and research barriers concerning cannabidiol and marijuana.","cite":{"label":"Sec. 401","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HC2B7155C8C71465497F382751AB40CCA:~:text=401.%20Federal%20research"}}],"unexpected":[{"category":"off_subject","items":[{"cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-HE03288F1531B47E1846ADB7F11A45E20:~:text=3.%20Determination%20of%20budgetary%20effects"},"heading":"Determination of budgetary effects","effect":"Directs that the budgetary effects of the Act under the Statutory Pay-As-You-Go Act of 2010 be determined by reference to a statement printed in the Congressional Record by the House Budget Committee chair.","amount":null,"quote":"shall be determined by reference to the latest statement titled “Budgetary Effects of PAYGO Legislation” for this Act"}]},{"category":"rule_delay","items":[{"cite":{"label":"Sec. 106","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr#toc-H26C3DD7C20734446BEC31733A4DA14B0:~:text=106.%20Prohibition%20against%20reinstating%20interdisciplinary%20review%20process"},"heading":"Prohibition against reinstating interdisciplinary review process for non-NIH-funded researchers","effect":"Bars the Secretary of Health and Human Services from reinstating the Public Health Service interdisciplinary review process described in a May 21, 1999 guidance, or requiring another review applicable only to marijuana research.","amount":null,"quote":"reinstate the Public Health Service interdisciplinary review process described in the guidance entitled “Guidance on Procedures for the Provision of Marijuana for Medical Research” (issued on May 21, 1999)"}]}],"version":{"type":"Enrolled Bill","date":null,"rule":"enrolled","href":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text/enr"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-10-15","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/117th-congress/house-bill/8454","text":"https://www.congress.gov/bill/117th-congress/house-bill/8454/text"},"card":{"image":"card/item/117-hr-8454.png","v":"4486b624c251","alt":"Votes on Record. H.R. 8454, 117th Congress: Medical Marijuana and Cannabidiol Research Expansion Act. House: 325 Yea, 95 Nay. Senate: voice vote. Outcome: Became law, 2 Dec 2022."}}